Deletion of RAGE Causes Hyperactivity and Increased Sensitivity to Auditory Stimuli in Mice
Open Access
- 15 December 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (12), e8309
- https://doi.org/10.1371/journal.pone.0008309
Abstract
The receptor for advanced glycation end-products (RAGE) is a multi-ligand receptor that belongs to the immunoglobulin superfamily of cell surface receptors. In diabetes and Alzheimer's disease, pathological progression is accelerated by activation of RAGE. However, how RAGE influences gross behavioral activity patterns in basal condition has not been addressed to date. In search for a functional role of RAGE in normal mice, a series of standard behavioral tests were performed on adult RAGE knockout (KO) mice. We observed a solid increase of home cage activity in RAGE KO. In addition, auditory startle response assessment resulted in a higher sensitivity to auditory signal and increased prepulse inhibition in KO mice. There were no significant differences between KO and wild types in behavioral tests for spatial memory and anxiety, as tested by Morris water maze, classical fear conditioning, and elevated plus maze. Our results raise a possibility that systemic therapeutic treatments to occlude RAGE activation may have adverse effects on general activity levels or sensitivity to auditory stimuli.This publication has 30 references indexed in Scilit:
- Neural-Activity-Dependent Release of S100B from Astrocytes Enhances Kainate-Induced Gamma OscillationsIn VivoJournal of Neuroscience, 2008
- Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic DysfunctionJournal of Neuroscience, 2008
- Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infectionCritical Care, 2007
- Impact of S100B on local field potential patterns in anesthetized and kainic acid‐induced seizure conditions in vivoEuropean Journal of Neuroscience, 2007
- RAGE Control of Diabetic Nephropathy in a Mouse ModelDiabetes, 2006
- Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK‐1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migrationJournal of Neurochemistry, 2004
- Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cellsMolecular Immunology, 2004
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Overexpression of a calcium-binding protein, S100 beta, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice.Learning & Memory, 1995
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984